Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0G9OC
|
||||
| Former ID |
DPR000173
|
||||
| Drug Name |
BMS-PCSK9
|
||||
| Drug Type |
Antisense drug
|
||||
| Indication | Coronary artery disease [ICD9: 410-414, 429.2; ICD10:I20-I25] | Preclinical | [551053] | ||
| Company |
ISIS Pharm; Bristol-Myers Squibb
|
||||
| Target and Pathway | |||||
| Target(s) | mRNA of proprotein convertase subtilisin/kexin type 9 | Target Info | [551053] | ||
| WikiPathways | PCSK9-mediated LDLR degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.